Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes (original) (raw)

• Kahn, S.E., Hull, R.L. & Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840–846 (2006).
  Article CAS PubMed Google Scholar
• Njajou, O.T. et al. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab. Res. Rev. 25, 733–739 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bendtzen, K. et al. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232, 1545–1547 (1986).
  Article CAS PubMed Google Scholar
• Spranger, J. et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812–817 (2003).
  Article CAS PubMed Google Scholar
• Larsen, C.M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517–1526 (2007).
  Article CAS PubMed Google Scholar
• Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).
  Article CAS PubMed Google Scholar
• Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674–677 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847–856 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Clark, A. et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 9, 151–159 (1988).
  CAS PubMed Google Scholar
• Cooper, G.J. et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84, 8628–8632 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Westermark, P. et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. USA 84, 3881–3885 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Butler, A.E. et al. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 53, 1509–1516 (2004).
  Article CAS PubMed Google Scholar
• Janson, J. et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl. Acad. Sci. USA 93, 7283–7288 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Verchere, C.B. et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc. Natl. Acad. Sci. USA 93, 3492–3496 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Howard, C.F. Jr. Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29, 301–306 (1986).
  Article PubMed Google Scholar
• Seino, S. S20G mutation of the amylin gene is associated with type II diabetes in Japanese. Study Group of Comprehensive Analysis of Genetic Factors in Diabetes Mellitus. Diabetologia 44, 906–909 (2001).
  Article CAS PubMed Google Scholar
• Ma, Z. et al. Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid 8, 242–249 (2001).
  Article CAS PubMed Google Scholar
• Udayasankar, J. et al. Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets. Diabetologia 52, 145–153 (2009).
  Article CAS PubMed Google Scholar
• Westermark, P., Eizirik, D.L., Pipeleers, D.G., Hellerstrom, C. & Andersson, A. Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38, 543–549 (1995).
  Article CAS PubMed Google Scholar
• Westermark, G.T., Westermark, P., Berne, C. & Korsgren, O. Widespread amyloid deposition in transplanted human pancreatic islets. N. Engl. J. Med. 359, 977–979 (2008).
  Article CAS PubMed Google Scholar
• Lorenzo, A., Razzaboni, B., Weir, G.C. & Yankner, B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368, 756–760 (1994).
  Article CAS PubMed Google Scholar
• Janson, J., Ashley, R.H., Harrison, D., McIntyre, S. & Butler, P.C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491–498 (1999).
  Article CAS PubMed Google Scholar
• Zraika, S. et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 52, 626–635 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zraika, S. et al. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia 53, 1046–1056 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Badman, M.K., Pryce, R.A., Charge, S.B., Morris, J.F. & Clark, A. Fibrillar islet amyloid polypeptide (amylin) is internalised by macrophages but resists proteolytic degradation. Cell Tissue Res. 291, 285–294 (1998).
  Article CAS PubMed Google Scholar
• de Koning, E.J. et al. Macrophages and pancreatic islet amyloidosis. Amyloid 5, 247–254 (1998).
  Article CAS PubMed Google Scholar
• Gitter, B.D., Cox, L.M., Carlson, C.D. & May, P.C. Human amylin stimulates inflammatory cytokine secretion from human glioma cells. Neuroimmunomodulation 7, 147–152 (2000).
  Article CAS PubMed Google Scholar
• Yates, S.L. et al. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74, 1017–1025 (2000).
  Article CAS PubMed Google Scholar
• Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 187, 61–70 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sharp, F.A. et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. USA 106, 870–875 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Keller, M., Ruegg, A., Werner, S. & Beer, H.D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818–831 (2008).
  Article CAS PubMed Google Scholar
• Hay, D.L., Christopoulos, G., Christopoulos, A., Poyner, D.R. & Sexton, P.M. Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol. Pharmacol. 67, 1655–1665 (2005).
  Article CAS PubMed Google Scholar
• Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9, 857–865 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hamon, Y. et al. Interleukin-1β secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 90, 2911–2915 (1997).
  CAS PubMed Google Scholar
• Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136–140 (2010).
  Article CAS PubMed Google Scholar
• Boni-Schnetzler, M. et al. Increased interleukin (IL)-1β messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation. J. Clin. Endocrinol. Metab. 93, 4065–4074 (2008).
  Article PubMed PubMed Central Google Scholar
• Maedler, K. et al. Glucose-induced beta cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851–860 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Welsh, N. et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54, 3238–3244 (2005).
  Article CAS PubMed Google Scholar
• Miller, Y.I. et al. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278, 1561–1568 (2003).
  Article CAS PubMed Google Scholar
• Apolinario, E. et al. Minimally modified (electronegative) LDL– and Anti-LDL– autoantibodies in diabetes mellitus and impaired glucose tolerance. Int. J Atheroscler. 1, 42–47 (2006).
  CAS Google Scholar
• Yano, M. et al. Increased electronegative charge of serum low-density lipoprotein in patients with diabetes mellitus. Clin. Chim. Acta 340, 93–98 (2004).
  Article CAS PubMed Google Scholar
• Abderrahmani, A. et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 50, 1304–1314 (2007).
  Article CAS PubMed Google Scholar
• Bauernfeind, F.G. et al. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787–791 (2009).
  Article CAS PubMed Google Scholar
• Matveyenko, A.V. & Butler, P.C. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J. 47, 225–233 (2006).
  Article CAS PubMed Google Scholar
• Hull, R.L. et al. Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52, 372–379 (2003).
  Article CAS PubMed Google Scholar
• Butler, A.E., Janson, J., Soeller, W.C. & Butler, P.C. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52, 2304–2314 (2003).
  Article CAS PubMed Google Scholar
• van de Veerdonk, F.L. et al. Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 107, 3030–3033 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015–3025 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Russell, J.C. & Proctor, S.D. Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats. Br. J. Pharmacol. 151, 216–225 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Michalska, M., Wolf, G., Walther, R. & Newsholme, P. The effects of pharmacologic inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2 -induced mouse islet or clonal pancreatic beta cell dysfunction. Biosci. Rep., published online doi:10.1042/BSR20090138 (23 February 2010).
• Nilsson, M.R. Techniques to study amyloid fibril formation in vitro. Methods 34, 151–160 (2004).
  Article CAS PubMed Google Scholar
• Wang, F., Hull, R.L., Vidal, J., Cnop, M. & Kahn, S.E. Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50, 2514–2520 (2001).
  Article CAS PubMed Google Scholar